<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33060297</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>44</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>03</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and C.</ArticleTitle><Pagination><StartPage>27598</StartPage><EndPage>27607</EndPage><MedlinePgn>27598-27607</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2014940117</ELocationID><Abstract><AbstractText>Human rhinoviruses (RVs) are positive-strand RNA viruses that cause respiratory tract disease in children and adults. Here we show that the innate immune signaling protein STING is required for efficient replication of members of two distinct RV species, RV-A and RV-C. The host factor activity of STING was identified in a genome-wide RNA interference (RNAi) screen and confirmed in primary human small airway epithelial cells. Replication of RV-A serotypes was strictly dependent on STING, whereas RV-B serotypes were notably less dependent. Subgenomic RV-A and RV-C RNA replicons failed to amplify in the absence of STING, revealing it to be required for a step in RNA replication. STING was expressed on phosphatidylinositol 4-phosphate (PI4P)-enriched membranes and was enriched in RV-A16 compared with RV-B14 replication organelles isolated in isopycnic gradients. The host factor activity of STING was species-specific, as murine STING (mSTING) did not rescue RV-A16 replication in STING-deficient cells. This species specificity mapped primarily to the cytoplasmic, ligand-binding domain of STING. Mouse-adaptive mutations in the RV-A16 2C protein allowed for robust replication in cells expressing mSTING, suggesting a role for 2C in recruiting STING to RV-A replication organelles. Palmitoylation of STING was not required for RV-A16 replication, nor was the C-terminal tail of STING that mediates IRF3 signaling. Despite co-opting STING to promote its replication, interferon signaling in response to STING agonists remained intact in RV-A16 infected cells. These data demonstrate a surprising requirement for a key host mediator of innate immunity to DNA viruses in the life cycle of a small pathogenic RNA virus.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McKnight</LastName><ForeName>Kevin L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0002-9099-2044</Identifier><AffiliationInfo><Affiliation>Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swanson</LastName><ForeName>Karen V</ForeName><Initials>KV</Initials><Identifier Source="ORCID">0000-0003-3105-0599</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austgen</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1714-8808</Identifier><AffiliationInfo><Affiliation>Research &amp; Development, GlaxoSmithKline, Collegeville, PA 19426.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research &amp; Development, GlaxoSmithKline, Collegeville, PA 19426.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Jonathan K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0003-1760-8998</Identifier><AffiliationInfo><Affiliation>Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGivern</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fritch</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research &amp; Development, GlaxoSmithKline, Collegeville, PA 19426.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remlinger</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research &amp; Development, GlaxoSmithKline, Collegeville, PA 19426.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magid-Slav</LastName><ForeName>Michal</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7272-5754</Identifier><AffiliationInfo><Affiliation>Research &amp; Development, GlaxoSmithKline, Collegeville, PA 19426.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapustina</LastName><ForeName>Maryna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Shihyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4867-6424</Identifier><AffiliationInfo><Affiliation>Research &amp; Development, GlaxoSmithKline, Collegeville, PA 19426; shihyun.k.you@gsk.com smlemon@med.unc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemon</LastName><ForeName>Stanley M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0003-1450-806X</Identifier><AffiliationInfo><Affiliation>Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; shihyun.k.you@gsk.com smlemon@med.unc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KL2 TR002490</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI103083</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI150095</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI153265</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494232">IRF3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532857">STING1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C530855">Sting1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C076023">2C protein, viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000623787">Rhinovirus A</SupplMeshName><SupplMeshName Type="Organism" UI="C000623728">Rhinovirus C</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003139" MajorTopicYN="N">Common Cold</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050838" MajorTopicYN="N">Interferon Regulatory Factor-3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054878" MajorTopicYN="N">Lipoylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cGAS</Keyword><Keyword MajorTopicYN="N">host range</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">phosphatidylinositol 4-phosphate</Keyword><Keyword MajorTopicYN="N">replication organelle</Keyword></KeywordList><CoiStatement>Competing interest statement: K.A., C.R., J.J., K.R., M.M.-S., and S.Y. are currently or were previously employees of GlaxoSmithKline.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>16</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33060297</ArticleId><ArticleId IdType="pmc">PMC7959528</ArticleId><ArticleId IdType="doi">10.1073/pnas.2014940117</ArticleId><ArticleId IdType="pii">2014940117</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jacobs S. E., Lamson D. M., St George K., Walsh T. J., Human rhinoviruses. Clin. Microbiol. Rev. 26, 135&#x2013;162 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A. C.et al. ., Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 324, 55&#x2013;59 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3923423</ArticleId><ArticleId IdType="pubmed">19213880</ArticleId></ArticleIdList></Reference><Reference><Citation>Cal&#x131;&#x15f;kan M.et al. ., Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N. Engl. J. Med. 368, 1398&#x2013;1407 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3755952</ArticleId><ArticleId IdType="pubmed">23534543</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez F. D., Childhood asthma inception and progression: Role of microbial exposures, susceptibility to viruses and early allergic sensitization. Immunol. Allergy Clin. North Am. 39, 141&#x2013;150 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613822</ArticleId><ArticleId IdType="pubmed">30954166</ArticleId></ArticleIdList></Reference><Reference><Citation>Britto C. J., Brady V., Lee S., Dela Cruz C. S., Respiratory viral infections in chronic lung diseases. Clin. Chest Med. 38, 87&#x2013;96 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679206</ArticleId><ArticleId IdType="pubmed">28159164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C. K., Callaway Z., Gern J. E., Viral infections and associated factors that promote acute exacerbations of asthma. Allergy Asthma Immunol. Res. 10, 12&#x2013;17 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5705478</ArticleId><ArticleId IdType="pubmed">29178673</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A. C., Gern J. E., Classification and evolution of human rhinoviruses. Methods Mol. Biol. 1221, 1&#x2013;10 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441521</ArticleId><ArticleId IdType="pubmed">25261302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov Y. A.et al. ., Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc. Natl. Acad. Sci. U.S.A. 112, 5485&#x2013;5490 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4418890</ArticleId><ArticleId IdType="pubmed">25848009</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwane M. K.et al. ., Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J. Infect. Dis. 204, 1702&#x2013;1710 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22013207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergroth E.et al. ., Rhinovirus type in severe bronchiolitis and the development of asthma. J. Allergy Clin. Immunol. Pract. 8, 588&#x2013;595.e4 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012669</ArticleId><ArticleId IdType="pubmed">31520837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizzintino J.et al. ., Association between human rhinovirus C and severity of acute asthma in children. Eur. Respir. J. 37, 1037&#x2013;1042 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024467</ArticleId><ArticleId IdType="pubmed">20693244</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N.et al. ., Novel human rhinoviruses and exacerbation of asthma in children. Emerg. Infect. Dis. 14, 1793&#x2013;1796 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2630738</ArticleId><ArticleId IdType="pubmed">18976575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu N. Y.et al. ., Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141, 799&#x2013;811 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienz K., Egger D., Pasamontes L., Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology 160, 220&#x2013;226 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">2820130</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Brey I., Bartenschlager R., Endoplasmic reticulum: The favorite intracellular niche for viral replication and assembly. Viruses 8, 160 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926180</ArticleId><ArticleId IdType="pubmed">27338443</ArticleId></ArticleIdList></Reference><Reference><Citation>Melia C. E.et al. ., Origins of enterovirus replication organelles established by whole-cell electron microscopy. MBio 10, e00951-19 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6561026</ArticleId><ArticleId IdType="pubmed">31186324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo H.et al. ., ACBD3 is an essential pan-enterovirus host factor that mediates the interaction between viral 3A protein and cellular protein PI4KB. MBio 10, e02742-18 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372799</ArticleId><ArticleId IdType="pubmed">30755512</ArticleId></ArticleIdList></Reference><Reference><Citation>Roulin P. S.et al. ., Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. Cell Host Microbe 16, 677&#x2013;690 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25525797</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernathy E.et al. ., Differential and convergent utilization of autophagy components by positive-strand RNA viruses. PLoS Biol. 17, e2006926 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6334974</ArticleId><ArticleId IdType="pubmed">30608919</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson W. T.et al. ., Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 3, e156 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1084330</ArticleId><ArticleId IdType="pubmed">15884975</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein K. A., Jackson W. T., Human rhinovirus 2 induces the autophagic pathway and replicates more efficiently in autophagic cells. J. Virol. 85, 9651&#x2013;9654 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165776</ArticleId><ArticleId IdType="pubmed">21752910</ArticleId></ArticleIdList></Reference><Reference><Citation>Brabec-Zaruba M., Berka U., Blaas D., Fuchs R., Induction of autophagy does not affect human rhinovirus type 2 production. J. Virol. 81, 10815&#x2013;10817 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2045498</ArticleId><ArticleId IdType="pubmed">17670838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablasser A., Chen Z. J., cGAS in action: Expanding roles in immunity and inflammation. Science 363, eaat8657 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30846571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa H., Barber G. N., STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674&#x2013;678 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2804933</ArticleId><ArticleId IdType="pubmed">18724357</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L.et al. ., MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28, 5014&#x2013;5026 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2519703</ArticleId><ArticleId IdType="pubmed">18559423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B.et al. ., The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538&#x2013;550 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18818105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W.et al. ., ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. U.S.A. 106, 8653&#x2013;8658 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2689030</ArticleId><ArticleId IdType="pubmed">19433799</ArticleId></ArticleIdList></Reference><Reference><Citation>Buehler E., Chen Y. C., Martin S., C911: A bench-level control for sequence specific siRNA off-target effects. PLoS One 7, e51942 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522603</ArticleId><ArticleId IdType="pubmed">23251657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa H., Ma Z., Barber G. N., STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788&#x2013;792 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664154</ArticleId><ArticleId IdType="pubmed">19776740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.et al. ., Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J. Virol. 78, 11061&#x2013;11069 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521849</ArticleId><ArticleId IdType="pubmed">15452226</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;pin G.et al. ., Activation of cGAS-dependent antiviral responses by DNA intercalating agents. Nucleic Acids Res. 45, 198&#x2013;205 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5224509</ArticleId><ArticleId IdType="pubmed">27694309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ergun S. L., Fernandez D., Weiss T. M., Li L., STING polymer structure reveals mechanisms for activation, hyperactivation, and inhibition. Cell 178, 290&#x2013;301.e10 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31230712</ArticleId></ArticleIdList></Reference><Reference><Citation>Haag S. M.et al. ., Targeting STING with covalent small-molecule inhibitors. Nature 559, 269&#x2013;273 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29973723</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh T.et al. ., Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. U.S.A. 106, 20842&#x2013;20846 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791563</ArticleId><ArticleId IdType="pubmed">19926846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Wu J., Du F., Chen X., Chen Z. J., Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786&#x2013;791 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863629</ArticleId><ArticleId IdType="pubmed">23258413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablasser A.et al. ., cGAS produces a 2&#x2032;&#x2013;5&#x2032;-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380&#x2013;384 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4143541</ArticleId><ArticleId IdType="pubmed">23722158</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa E., Mukai K., Saito K., Arai H., Taguchi T., The binding of TBK1 to STING requires exocytic membrane traffic from the ER. Biochem. Biophys. Res. Commun. 503, 138&#x2013;145 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29870684</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D.et al. ., STING directly activates autophagy to tune the innate immune response. Cell Death Differ. 26, 1735&#x2013;1749 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748081</ArticleId><ArticleId IdType="pubmed">30568238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X.et al. ., Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature 567, 262&#x2013;266 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417302</ArticleId><ArticleId IdType="pubmed">30842662</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris J. R., Racaniello V. R., Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J. Virol. 77, 4773&#x2013;4780 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152148</ArticleId><ArticleId IdType="pubmed">12663784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W. M.et al. ., Human rhinovirus species and season of infection determine illness severity. Am. J. Respir. Crit. Care Med. 186, 886&#x2013;891 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530215</ArticleId><ArticleId IdType="pubmed">22923659</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder J. E.et al. ., Human rhinovirus C: Age, season, and lower respiratory illness over the past 3 decades. J. Allergy Clin. Immunol. 131, 69&#x2013;77.e6 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748586</ArticleId><ArticleId IdType="pubmed">23146382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam E., Stein S., Falck-Pedersen E., Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. J. Virol. 88, 974&#x2013;981 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911663</ArticleId><ArticleId IdType="pubmed">24198409</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M.et al. ., Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Moreno J. S.et al. .; CAPNETZ Study Group , The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires&#x2019; disease in humans. PLoS Pathog. 14, e1006829 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770077</ArticleId><ArticleId IdType="pubmed">29298342</ArticleId></ArticleIdList></Reference><Reference><Citation>McKnight K. L., Lemon S. M., Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J. Virol. 70, 1941&#x2013;1952 (1996).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190023</ArticleId><ArticleId IdType="pubmed">8627720</ArticleId></ArticleIdList></Reference><Reference><Citation>McKnight K. L., The human rhinovirus internal cis-acting replication element (cre) exhibits disparate properties among serotypes. Arch. Virol. 148, 2397&#x2013;2418 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14648294</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane D.et al. ., Differential hepatitis C virus RNA target site selection and host factor activities of naturally occurring miR-122 3&#xb4; variants. Nucleic Acids Res. 45, 4743&#x2013;4755 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5416874</ArticleId><ArticleId IdType="pubmed">28082397</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienz K., Egger D., Rasser Y., Bossart W., Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology 131, 39&#x2013;48 (1983).</Citation><ArticleIdList><ArticleId IdType="pubmed">6316654</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z.et al. ., A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496, 367&#x2013;371 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631468</ArticleId><ArticleId IdType="pubmed">23542590</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>